您的位置: 首页 > 农业专利 > 详情页

NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY
专利权人:
THE SCRIPPS RESEARCH INSTITUTE
发明人:
REISFELD, RALPH A.,XIANG, RONG,LUO, YUNPING,LIAO, DEBBIE,LIU, ZE,CHEN, TINGMEI,CHEN, SI,LU, DAN
申请号:
CA2809617
公开号:
CA2809617A1
申请日:
2011.09.02
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
The present invention provides an aqueous tumor-targeting liposome nanoparticle composition comprising an aqueous dispersion of liposome nanoparticles. The nanoparticles preferably encapsulate an anti-cancer chemotherapeutic agent, which can be added to a pre-formed liposome composition or can be incorporated in the liposomes during the formation of the liposomes. The liposome nanoparticles comprise a legumain-targeting lipid admixed with one or more other micelle or vesicle-forming lipid materials in the form of nanoparticulate liposomes dispersed in an aqueous carrier. A preferred tumor-targeting liposome nanoparticle composition comprises (a) a legumain-targeting lipid component, (b) a zwitterionic lipid component (c) an amino-substituted lipid component (d) a neutral lipid component and (e) polyethylene glycol-conjugated lipid component. The legumain-targeting lipid component comprising a hydrophobic lipid portion covalenetly attached to a legumain-binding moiety.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充